-transparent.png){kind=logo}
The alpha 1-acid glycoprotein (orosomucoid) concentration in the serum of 34 uremic patients on chronic hemodialysis was measured twice at intervals of 3 months. In 80% of the cases the concentrations are above normal. Furthermore, the examination showed a correlation between the concentrations at the first and at the second measurement. No change in se-orosomucoid concentration was observed during hemodialysis. We therefore conclude that orosomucoid cannot be used as an acute phase reactant among uremic patients in chronic hemodialysis neither is it very likely that the hyperlipidemia and accelerated atherosclerosis in hemodialysis patients are due to lack of orosomucoid.
H J Henriksen, and
M U Petersen, and
F B Pedersen
January 1983,
Nephron,
H J Henriksen, and
M U Petersen, and
F B Pedersen
December 1982,
Quaderni Sclavo di diagnostica clinica e di laboratorio,
H J Henriksen, and
M U Petersen, and
F B Pedersen
September 1984,
Hiroshima journal of medical sciences,
H J Henriksen, and
M U Petersen, and
F B Pedersen
October 1972,
Ugeskrift for laeger,
H J Henriksen, and
M U Petersen, and
F B Pedersen
March 1999,
Wiener klinische Wochenschrift,
H J Henriksen, and
M U Petersen, and
F B Pedersen
December 1969,
The Journal of clinical investigation,
H J Henriksen, and
M U Petersen, and
F B Pedersen
January 1987,
Farmakologiia i toksikologiia,
H J Henriksen, and
M U Petersen, and
F B Pedersen
September 1992,
The Journal of pharmacology and experimental therapeutics,
H J Henriksen, and
M U Petersen, and
F B Pedersen
February 1991,
The International journal of artificial organs,
H J Henriksen, and
M U Petersen, and
F B Pedersen
July 1982,
Clinica chimica acta; international journal of clinical chemistry,
